LLLei Liu

Lei Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lei Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Liu

    Key Laboratory of Emergency and Trauma of Ministry of Education, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Hainan Medical University

    8 shared publications
  • Liang Li

    Respiratory and Critical Care Medicine Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

    3 shared publications
  • Yu Li

    Department of Respiratory Medicine, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China

    3 shared publications
  • Bin Liu

    Department of Respiratory Medicine, the First Affiliated Hospital of Hainan Medical University, Haikou 570100, China

    2 shared publications
  • Li-Li Zhu

    Department of Respiratory Medicine, the Fourth Affiliated Hospital of Harbin Medical University, No 37, Yi Yuan Street, Nan Gang District, Harbin 150001, China

    2 shared publications
  • Min Ye

    International School of Nursing, Hainan Medical University, Haikou 571199, China

    2 shared publications

Latest Publications

  • Open Access

    YtnP lactonase from Bacillus licheniformis T2 mitigates virulence and biofilm formation in carbapenem-resistant Acinetobacter baumannii via quorum sensing quenching

    by Bin Liu, Caihua Li, Yizhen Zhu, Mengxia Zhu, Jilai Yin, Lei Liu

    Backgroud: Carbapenem-resistant Acinetobacter baumannii (CRAB) has become a predominant nosocomial pathogen worldwide, with biofilm formation and quorum sensing (QS) primarily responsible for its high antimicrobial tolerance and clinical refractory infections. Targeting bacterial virulence rather than conventional bactericidal strategies represents a promising alternative to combat multidrug-resistant CRAB. Methods: In this study, we isolated a N-acyl homoserine lactonase YtnP from mangrove rhizosphere-derived Bacillus licheniformis T2. We comprehensively biochemically characterized the YtnP and systematically validated its potent quorum-quenching, antibiofilm and anti-virulence activities against clinical CRAB strains both in vitro and in vivo model. Results: YtnP is a 280-amino-acid metalloenzyme of approximately 30 kDa containing a conserved HXHXDH motif, exhibiting optimal activity at 37°C –45°C and pH 7.0–7.5. Distinct from classical lactonases, YtnP maintained high catalytic activity without exogenous Zn 2+ supplementation but was markedly inhibited by EDTA and excess Zn 2+ . Functional assays revealed that YtnP efficiently degraded the key QS signal 3-OH-C12-HSL with a degradation rate of 59.5% without affecting the planktonic growth of CRAB. YtnP significantly dismantled mature CRAB biofilms, reducing biofilm biomass by 55.56% and maximum thickness by 61.76%, and prominently downregulated the transcription of virulence-related outer membrane protein genes ompA and csuA/B by nearly 50% and 52.6%, respectively. In the Galleria mellonella model, YtnP remarkably alleviated CRAB metabolite-induced lethality and increased the 36-h larval survival rate nearly sixfold. Conclusion: Collectively, mangrove-derived YtnP acts as a potent quorum-quenching enzyme that suppresses CRAB biofilm formation and virulence in a non-bactericidal manner. This work highlights the potential of YtnP as a promising anti-virulence adjuvant candidate for the development of alternative therapeutic strategies against intractable CRAB infections.

  • Open Access

    Rapid Cavitary Pneumonia and Reversible Hepatic Injury in Burkholderia pseudomallei ST271 Infection

    by Nan Zhang, Liang Li, Fang Chen, Xun Kang, Lei Liu, Dai Kuang

    Rapid Cavitary Pneumonia and Reversible Hepatic Injury in Burkholderia pseudomallei ST271 Infection - Article abstract #951729


  • Open Access

    OmpW overexpression in meropenem-exposed Acinetobacter baumannii persister cells enhances virulence and reveals a candidate target

    by Bin Liu, Junan Wang, Jincheng Hu, Liang Li, Lei Liu

    Objective: Acinetobacter baumannii is one of the most drug-resistant microorganisms in hospital-acquired infections. The treatment of choice for A. baumannii infections is carbapenems (e.g., meropenem). However, A. baumannii can develop resistance to all clinical antibiotics associated with the formation of persister cells. We first assessed the virulence and differential expression levels of outer membrane protein W (OmpW) in A. baumannii persister cells and A. baumannii regular cells in vivo and in vitro after exposure to meropenem.Methods: Persister cells were confirmed using a standard method. OmpW characterization was performed using western blot analysis, and OmpW expression was detected using real-time polymerase chain reaction (PCR) after ribonucleic acid (RNA) extraction. An A. baumannii virulence assay was performed using the Galleria mellonella larvae model. Relative expression was calculated using the 2−ΔΔCT method.Results: The presence of bona fide A. baumannii persister cells was confirmed after 48 h of meropenem exposure at 15 μg/mL, with levels reaching 0.3216% of the initial bacterial population and a survival fraction of 0.081%. OmpW genes were highly expressed at more than 2.68-fold (p = 0.01) with meropenem exposure at 1 μg/mL and 8.61-fold (p = 0.0005) with meropenem exposure at 15 μg/mL. There was a significant difference in the lethal dose 50% (LD50) at 24 h postinfection between persister cells (2.01 × 105 CFU/larva) and regular cells (4.73 × 105 CFU/larva) at p < 0.05. Similarly, there was a significant difference between the LD50 at 48 h for persister cells (1.61 × 105 CFU/larva) and regular cells (4.08 × 105 CFU/larva) at p < 0.05. However, there was no statistically significant difference in the LD50 at 72, 96, and 120 h postinfection.Conclusion: OmpW overexpression in meropenem-exposed A. baumannii persister cells enhances virulence and reveals a candidate target for preventing and controlling A. baumannii persister cells.


  • Retraction
    Open Access

    RETRACTED: Ye et al. Drug Resistance and Molecular Characteristics of Carbapenem-Resistant OXA-48-Producing Klebsiella pneumoniae Strains in Hainan, China. Microorganisms 2024, 12, 49

    by Min Ye, Lei Liu, Bin Liu, Xiangdong Zhou, Qi Li

    The author retracts the article, ‘Drug Resistance and Molecular Characteristics of Car-bapenem-Resistant OXA-48-Producing Klebsiella pneumoniae Strains in Hainan, China’


  • Retracted
    Open Access

    RETRACTED: Drug Resistance and Molecular Characteristics of Carbapenem-Resistant OXA-48-Producing Klebsiella pneumoniae Strains in Hainan, China

    by Min Ye, Lei Liu, Bin Liu, Xiangdong Zhou, Qi Li

    Background: The emergence and global spread of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) are of great concern to health services worldwide. These β-lactamases hydrolyze almost all β-lactams, are plasmid-encoded, and are easily transferable among bacterial species. They are mostly of the KPC types in CR-hvKp. OXA-48-producing hvKP strains have been rarely reported in the literature. Methods: OXA-48-producing hvKP strains were collected from clinical specimens at the First Affiliated Hospital of Hainan Medical University from January 2022 to March 2023. Hypervirulent strains were tested for virulence in a mouse lethality study and underwent whole genome sequencing to identify genomic features. Results: A total of 42 unique OXA-48-bearing K. pneumoniae strains were identified, including three CR-hvKP strains (KP2683-1, NCRE61, and KP2185), which were isolated from bacteremia, pulmonary abscess, and liver abscess separately. The three CR-hvKP strains belonged to two different clones of ST11 KL64 (KP2185 and NCRE61) and ST23 K1 (KP2683-1). The KP2683-1 strain had the highest virulence. Whole genome sequencing analysis indicated that NCRE61 and KP2185 acquired IncFIB-type plasmids with a set of virulence genes (iroBCDN, iucABCD, iutA, rmpA, and rmpA2), while KP2683-1 acquired an IncL-type blaOXA-48-harboring plasmid. Consecutive cultures showed that the blaOXA-48-harboring plasmids were highly stable in the three hvKP strains and could be transmitted to Escherichia coli J53 by conjugation. The drug susceptibility testing results show that Ceftazidime/avibactam is sensitive for OXA-48-producing hvKP. Conclusions: Our study highlighted the two evolutionary pathways of OXA-48-producing hvKP strains and confirmed their virulence through in vivo testing. Ceftazidime/avibactam may be a viable option for treating OXA-48-producing hvKP strains.


  • Open Access

    Myrtenol Inhibits Biofilm Formation and Virulence in the Drug-Resistant Acinetobacter baumannii: Insights into the Molecular Mechanisms

    by Lei Liu, Bin Liu, Liang Li, Ming-Xin He, Xiang-Dong Zhou, Qi Li

    Background: blaNDM-1-producing Acinetobacter baumannii (BP-AB) remains a critical problem in nosocomial infections, because of its resistance mediated by the biofilm formation and virulence factors. No studies have confirmed myrtenol’s efficacy in inhibiting the biofilm formation and virulence associated with biofilm of BP-AB. Methods: The tested concentrations of myrtenol were wild type (A), 50 μg/mL (B), 100 μg/mL (C), 200 μg/mL (D), 250 μg/mL (E), and 300 μg/mL (F). Results: The BP-AB biofilm inhibition was significantly higher in the D, E, and F groups than in the A, B, and C groups. Myrtenol significantly reduced the air-liquid interface ring formation in glass tubes. It also effectively inhibited the attachment of BP-AB strains on polystyrene surfaces as shown by crystal violet staining. Microscopy showed a significant reduction in biofilm formation with dispersed BP-AB strains. The confocal laser scanning microscopy analysis showed a significant reduction in the biofilm’s biomass, covered surface area, and thickness. The scanning electron microscopy analysis revealed significantly fewer BP-AB aggregates on the coverslip surface. In the CompStat analysis, the biofilm’s biomass, maximum thickness, and surface-to-volume ratio were significantly reduced. The qPCR analysis revealed a significant down-regulation of bfmR, bap, csuA/B, and ompA expression, which positively correlated with the biofilm’s biomass, maximum thickness, and surface-to-volume ratio in BP-AB strains. Myrtenol significantly improved the susceptibility of BP-AB to the antibiotics amikacin, piperacillin/tazobactam, cefoperazone/sulbactam, and ceftazidime. Conclusion: Myrtenol attenuates the BP-AB biofilm formation and virulence by suppressing the expression of bfmR, bap, csuA/B, and ompA.


  • Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital

    by Qiu‐Yan Li, Bin Liu, Lei Liu

    What is known and Objective The purpose of this study was to investigate the effect of imposing infection control programmes (ICPs) and antimicrobial stewardship (AMS) by monitoring the antimicrobial resistance of Pseudomonas aeruginosa. Methods Antimicrobial susceptibility testing was performed in accordance with the Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines. ICPs and AMS were initiated at the Fourth Hospital from 2013 to 2018. Results and discussion A total of 2,886 P. aeruginosa isolates were assessed. The antimicrobial resistance trends of the P. aeruginosa strains improved after the intervention measures. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) P. aeruginosa contributed to 18.5% and 3.5% of the total P. aeruginosa strains, respectively. Colistin was the most effective antibiotic against 97.6% of XDR-P. aeruginosa and 99.41% of MDR-P. aeruginosa. The consumption of alcohol-based hand gel (ABHG) increased from 0.6 L to 10.8 L per 1,000 patient-days (PD) (p = 0.005). The yearly consumption of antibiotics decreased from 45 to 37.5 defined daily doses (DDD) per 1,000 PD(p = 0.04). After 2013, the incidence rate of MDR-P. aeruginosa showed a significant decrease from 22% to 14.1% (p = 0.04), and XDR-P. aeruginosa decreased from 5.8% to 0.9%. The use of ABHG was negatively related to MDR-P. aeruginosa morbidity (r = -0.86; p = 0.021). The consumption of antibiotics was positively related to MDR-P. aeruginosa morbidity (r = 0.86; p = 0.021). What is new and Conclusion Successful control of MDR-P. aeruginosa resistance was achieved by imposing comprehensive ICPs and AMS.


  • Open Access

    Molecular Epidemiology and Mechanisms of Carbapenem-Resistant Acinetobacter baumannii Isolates from ICU and Respiratory Department Patients of a Chinese University Hospital

    by Bin Liu, Lei Liu

    Background: The objective of our study is to estimate the differences in molecular epidemiology and resistance mechanisms in carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from the ICU and respiratory department(RD) in Fourth Affiliated Hospital of Harbin Medical University. Methods: Carbapenemase genes associated with carbapenem resistance were studied by polymerase chain reaction(PCR). Genotyping was analyzed using multi-locus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE). Results: Sixty non-duplicate CRAB isolates from the ICU and RD (n=30, respectively) were collected. All of CRAB strains were not resistant to colistin (0%). The CRAB strains from the ICU were significantly more resistant to tigecycline and cefoperazone/sulbactam compared with the RD (23.3% vs 0%, P=0.03; 53.3% % vs 23.3%, P=0.01, respectively). PCR detection of genes associated with CRAB revealed that the ratio in both the ICU and the RD of blaVIM-2, blaIMP-4, blaNDM-1, blaOXA-23, ampC, and mutation of CarO were present in 23.3% vs 0% (P=0.01), 40% vs 10% (P=0.02), 20% vs 0% (P=0.02), 80% vs 56.7%, 16.7% vs 13.3% and 86.7% vs 60% (P=0.04), respectively. Seven genotypes were detected by the PFGE in the RD and the ICU, respectively. Genotype I was significantly more frequent in the ICU compared with the RD (63.3% vs 36.6%, P=0.03). MLST showed that there were 10 ST genotypes in the RD and four in the ICU, but ST92 in both groups was 33.3% vs 63.3% (P=0.03), respectively. Conclusion: There are differences in molecular epidemiology and resistance mechanisms in the CRAB isolates between the ICU and RD.


  • Open Access

    Successful control of resistance in Pseudomonas aeruginosa using antibiotic stewardship and infection control programs at a Chinese university hospital: a 6-year prospective study

    by Lei Liu, Bin Liu, Yu Li, Wei Zhang

    Objective: Pseudomonas aeruginosa is emerging as a highly multidrug-resistant (MDR) nosocomial pathogen. Data on the efficacy of infection control measures in endemic situations are lacking. We investigated the effect of antimicrobial stewardship (AMS) and infection control programs (ICPs) in controlling the resistance of P. aeruginosa at a tertiary hospital center. Methods: Susceptibility and resistance were investigated using broth microdilution, as per the guidelines of the Clinical and Laboratory Standards Institute. Antibiotic use was restricted through AMS, which included a classification management system for antibiotic use. The ICPs included environmental cleaning and disinfection, hand hygiene, active surveillance of P. aeruginosa, and education about infection control. Results: A total of 2,241 P. aeruginosa isolates were evaluated between 2012 and 2017. Sensitivity and resistance of the isolates to the antipseudomonal antimicrobials colistin and tigecycline were stable. The sensitivity and resistance to other antipseudomonal antimicrobials improved after 2014, after the AMS and ICPs were implemented in 2013. The use of alcohol-based hand gel significantly increased from 0.6 to 10.9 L per 1,000 patient-days (PD) during the study period (P=0.005). The incidence rates of extensively drug-resistant (XDR) and MDR P. aeruginosa showed a sustained decrease from 2013 (4.9 and 22%) to 2017 (1 and 15%), respectively. The yearly consumption of antimicrobial agents also showed a sustained and significant decrease from 45 defined daily doses (DDDs) per 1,000 PD to 38.15 DDDs per 1,000 PD (P=0.04). A significant correlation was found between the incidence rate of MDR P. aeruginosa and the consumption of antimicrobial agents (P=0.01). Conclusion: Monitoring of P. aeruginosa, AMS, and comprehensive ICPs could be one of the best and effective methods to prevent the development of resistance in P. aeruginosa.


  • CYFRA21-1 as a Serum Tumor Marker for Follow-Up Patients with Squamous Cell Lung Carcinoma and Oropharynx Squamous Cell Carcinoma

    by Lei Liu, Bin Liu, Li-Li Zhu, Yu Li

    To evaluate serum soluble fragments of cytokeratin 19 (i.e., CYFRA21-1) as a tumor marker for patients with squamous cell lung carcinoma (SCLC) and oropharynx squamous cell carcinoma (OSCC). A total of 152 patients with SCLC and OSCC, and 84 control patients were included in the study. CYFRA21-1 concentration was measured using electrochemiluminescence immunoassays. As the disease stages increased, concentrations and sensitivity of CYFRA21-1 increased significantly in patients with SCLC and OSCC. A significant difference in sensitivity between the pretherapeutic group and recurrence group of OSCC (p = 0.001) was observed, as well as for SCLC (p = 0.024). A positive correlation (p = 0.042) existed between CYFRA21-1 concentrations and cancer stage of SCLC and OSCC. There was no significant correlation between CYFRA21-1 concentrations and different organ types with squamous cell cancer (p = 0.51). The CYFRA21-1 assay demonstrated a greater sensitivity for recurrent stages of SCLC and OSCC, and may prove beneficial in the prediction of SCLC and OSCC recurrence at an earlier date.